Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
IronCalc brings fast, Excel-compatible spreadsheets to your browser without locking you into Microsoft 365 or Google’s cloud.